
Market Access
Get to market faster – for your patients.
Unlock the true potential of your products and showcase their value and impact to stakeholders across Europe.
Access strategies
that deliver value.
Securing access in today’s healthcare landscape is more complex than ever. Rising cost pressures and empowered payers can limit even the most promising therapies from reaching those who need them most.
athagoras helps you navigate this landscape with confidence. We craft tailored market access strategies that optimize pricing, accelerate reimbursement, and strengthen your value story for EU HTA and national decision-makers.
With deep expertise in European systems, we simplify the complexities of cross-border coordination, align stakeholder engagement, and minimize costly delays – so you can unlock the full value of your innovation.

Our solutions
Strategy that opens markets.
Market Access Strategy and Recommendations
Align with market realities. Accelerate access. Maximize value.
Successful market entry starts with smart strategy. athagoras delivers the insights you need to navigate competitive landscapes, optimize launch sequencing, and address unmet needs with precision.
By analyzing key factors – like disease burden, payer expectations, and local regulations – we help you build tailored strategies that drive faster access and long-term commercial success. With our guidance, your approach stays grounded in real-world dynamics and focused on value at every stage.
- Evaluation of commercial potential in Europe
- Reimbursement / treatment pattern studies
- Price estimations and optimal launch sequencing
- Market research
- Advisory boards and expert panels
HTA and Value Dossier
Make the value of your product undeniable.
Health Technology Assessment (HTA) and Health Economics and Outcomes Research (HEOR) are essential to proving your product’s worth to payers and healthcare systems.
athagoras helps you build a compelling, data-driven value story that supports pricing, reimbursement, and market access. As Joint Clinical Assessments (JCA) gain prominence, we ensure your evidence package aligns with both regulatory and reimbursement expectations – accelerating decisions and expanding access across markets.
- HTA pathway optimization
- Full-service HTA submissions
- Compilation of value dossiers
Health Economic Modelling
Quantify value. Strengthen your case. Win payer support.
Evidence-backed value is key to securing market access. athagoras develops robust health economic models that clearly demonstrate the clinical and economic impact of your product – supporting pricing, reimbursement, and strategic decision-making.
From early-stage planning to HTA submissions, our models are tailored to your indication, therapeutic area, and target markets. With deep expertise in cost-effectiveness, budget impact, and burden of disease analyses, we help you deliver a credible, compelling case to payers and decision-makers.
- Global and local cost effectiveness analysis
- Budget impact analysis
- Value tools
Pricing & Negotiations Support
Pricing with impact. Entry with intent.
Pricing is a critical lever in your market strategy – impacting access, profitability, and long-term growth. athagoras helps you develop smart, sustainable pricing strategies that align with payer expectations and your commercial objectives.
We analyze reference pricing, stakeholder dynamics, and market benchmarks to guide decisions from launch through post-launch. The result: optimized pricing that supports reimbursement, drives value, and unlocks the full potential of your product.
- Pricing strategy
- Negotiation training
- Negotiation support
Health Systems
Navigate Europe’s diverse healthcare landscapes with precision.
Understanding the intricacies of European health systems is crucial for successful market access. athagoras provides in-depth analyses of national healthcare infrastructures, reimbursement mechanisms, and policy environments. By aligning your product’s value proposition with the specific needs and structures of each health system, we ensure optimized access strategies and sustainable market presence.
- Comprehensive analysis of national healthcare systems
- Assessment of reimbursement framework and funding pathways
- Strategic alignment with health policy and regulatory requirements
- Identification of key stakeholders and decision-making processes

Get in touch
Let’s move life sciences forward – together.
End-to-end support,
wherever your project starts.